Showing promise in the landscape of excess body fat treatment, retatrutide is a different approach. Unlike many available medications, retatrutide operates as a double agonist, at once affecting both GLP-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) sensors. The concurrent engagement promotes multiple advantageous ef